A CCR8 ANTAGONIST ANTIBODY IN COMBINATION WITH A LYMPHOTOXIN BETA RECEPTOR AGONIST… Application WO-2022117569-A1 World Intellectual Property Organisation (WIPO) 09 Jun 2022